AZD2014 plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Trial Identifier:	D2276C00001
Sponsor:	AstraZeneca
NCTID::	NCT02780830
Start Date:	June 2016
Primary Completion Date:	April 2019
Study Completion Date:	April 2019
Condition:	Non-Hodgkin's Lymphoma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.